Latest filing: trade of 13 Nov 2022 for BIRZEIT PHARMACEUTICALS. The register gives no publication date.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Razan Center For Infertility: trading record in brief
All filings by Razan Center For Infertility on record concern Birzeit Pharmaceuticals. The record holds 3 filings, for trades running from 18 October 2022 to 13 November 2022.
Purchases make up the whole of the open-market record (3 purchases). The totals do not cover 3 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Most recently, on 13 November 2022, the filings show an open-market purchase in Birzeit Pharmaceuticals. These figures are compiled from regulatory filings published by PCMA / Palestine Exchange. They describe what insiders did and are not a recommendation.
Companies and markets linked to Razan Center For Infertility
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,121 sharesSharePEXPEX:abfd4af8d593-1Canonical exit: 11 Feb 2023 (T+90)
- 500 sharesSharePEXPEX:225171f69bfc-1Canonical exit: 30 Jan 2023 (T+90)
- 3,896 sharesSharePEXPEX:71ffb7456a23-1Canonical exit: 16 Jan 2023 (T+90)
3 of 3 declarations